Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Environ Contam Toxicol ; 51(2): 237-43, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16783621

RESUMO

The pharmaceutical estrogen 17alpha-ethinylestradiol (EE2) and the anabolic androgen 17beta-trenbolone (Tb) can interfere with the endocrine and reproductive systems of fish. The potency of these chemicals in zebrafish (Danio rerio) and Japanese medaka (Oryzias latipes) was assessed using the core end points vitellogenin (Vtg) concentration at 38 days post-hatch and sex ratio and gonad morphology at 60 days post-hatch. Vtg concentrations were measured in fish whole-body homogenate samples using enzyme-linked immunosorbent assay. Increased Vtg concentration and feminization of fish after exposure to 10 ng/L EE2, as well as masculinization after exposure to 50 ng/L of Tb, were observed in zebrafish. Intersex was observed in medaka exposed to EE2. A decrease in Vtg production after Tb exposure (50 ng/L) was measured in both zebrafish and medaka. Analyses of gonad morphology revealed increased testicular area and sperm percentage in Tb-exposed zebrafish, whereas increased sperm percentage was measured in Tb-exposed medaka. The higher sensitivity of zebrafish compared with medaka to both EE2 and Tb was revealed in the study.


Assuntos
Etinilestradiol/toxicidade , Oryzias/fisiologia , Acetato de Trembolona/toxicidade , Peixe-Zebra/fisiologia , Animais , Feminino , Masculino , Oócitos/efeitos dos fármacos , Oócitos/crescimento & desenvolvimento , Razão de Masculinidade , Espermatozoides/efeitos dos fármacos , Espermatozoides/crescimento & desenvolvimento , Testículo/efeitos dos fármacos , Testículo/crescimento & desenvolvimento , Vitelogeninas/análise
2.
J Ethnopharmacol ; 73(1-2): 95-100, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11025144

RESUMO

This study was performed on anaesthetized male Wistar rats that received a continuous intravenous perfusion during 1.25 h of an aqueous extract of aerial parts of Urtica dioica L. (Urticaceae) at a low dose of 4 mg/kg/h or at a high dose of 24 mg/kg/h, or furosemide (control diuretic) at a dose of 2 mg/kg/h. As compared with a control period in each rat, the arterial blood pressure was reduced proportionally to the dose of the perfusion of the plant extract (15 and 38%, P<0.001, respectively). These effects were accompanied by a correlative increase of diuresis (11 and 84%, P<0. 001, respectively) and natriuresis (28 and 143%, P<0.001, respectively). In the rats perfused by furosemide, the arterial blood pressure was reduced by 28% (P<0.001). The diuresis and natriuresis were also increased proportionally in this case (85 and 155%, P<0.001, respectively). Nevertheless, the hypotensive action of U. dioica was reversible during the recovery periods in about 1 h with the lower dose of the plant extract and furosemide, while the effect of the higher dose was persistent, indicating a possible toxic effect. In conclusion, the results demonstrate an acute hypotensive action of U. dioica that indicates a direct effect on the cardiovascular system. Moreover, diuretic and natriuretic effects were also observed, suggesting an action on the renal function. Finally, the plant extract seems to have a toxic effect at the higher dose.


Assuntos
Anti-Hipertensivos/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Diuréticos/farmacologia , Magnoliopsida , Natriurese/efeitos dos fármacos , Extratos Vegetais/farmacologia , Análise de Variância , Animais , Anti-Hipertensivos/administração & dosagem , Diurese/efeitos dos fármacos , Diuréticos/administração & dosagem , Relação Dose-Resposta a Droga , Furosemida/farmacologia , Infusões Intravenosas , Masculino , Extratos Vegetais/administração & dosagem , Extratos Vegetais/isolamento & purificação , Ratos , Ratos Wistar
3.
Brain Dev ; 15(5): 346-55, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-7506498

RESUMO

Eighteen patients, 16 boys and 2 girls, aged 5-14 years, with subacute sclerosing panencephalitis (SSPE) were treated with oral isoprinosine (100 mg/kg/day) and intraventricular alpha-interferon 2b (Intron A, Schering Corp.), starting at 500,000 U twice a week and later increasing to 3 million U biweekly. Minimal follow-up of living patients is 12 months; maximal 40 months. On the basis of the Neurological Disability Index (NDI) scores and staging, 8 have treatment-induced remissions (3 improved, 5 arrested), 4 are worse and 6 died. This 44% (8/18) rate of remission/improvement compares well with the 9% (1/11) remission in historical controls in the same institution (p = < 0.05) and 5% spontaneous remission in the literature. Combined oral isoprinosine-intraventricular alpha-interferon appears to be an effective treatment for SSPE.


Assuntos
Inosina Pranobex/uso terapêutico , Interferon-alfa/uso terapêutico , Panencefalite Esclerosante Subaguda/tratamento farmacológico , Administração Oral , Adolescente , Criança , Pré-Escolar , Quimioterapia Combinada , Eletroencefalografia , Feminino , Humanos , Injeções Intraventriculares , Inosina Pranobex/administração & dosagem , Interferon alfa-2 , Interferon-alfa/administração & dosagem , Imageamento por Ressonância Magnética , Masculino , Proteínas Recombinantes , Panencefalite Esclerosante Subaguda/diagnóstico por imagem , Panencefalite Esclerosante Subaguda/patologia , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...